Infection in the bone marrow transplant recipient.
Bone marrow transplantation (BMT) is widely used in the treatment of myelodysplastic disorders and leukemia. Despite improvements in patient management, infection as a consequence of the immunodeficiency states that follow BMT remains a significant cause of morbidity and mortality. This article provides an overview of the major infections after BMT with an emphasis on new developments in diagnosis, treatment, and prophylaxes that have occurred in recent years.
Walter
E A
EA
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA.
Bowden
R A
RA
D001424:Bacterial Infections / Q000209:etiology* / Q000517:prevention & control; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D009181:Mycoses / Q000209:etiology* / Q000517:prevention & control; D012307:Risk Factors; D014777:Virus Diseases / Q000209:etiology* / Q000517:prevention & control